Stay Tuned to the LDL Controversy
March 2017
Debate continues about when to monitor and how to manage LDL.
We know the new thinking is to use target DOSES of statins to reduce CV risk...instead of titrating to a specific LDL goal.
But don't use a "fire and forget" approach.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote